Log in

6915 Jiangxi Institute of Biological Products Inc. HKEX · China

Jiangxi Institute of Biological Products (6915) news

Jiangxi Institute of Biological Products Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6915, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Jiangxi Institute of Biological Products news

We have not published a story on Jiangxi Institute of Biological Products yet. When there is news, it will appear here.

Questions about Jiangxi Institute of Biological Products

What is the ticker symbol of Jiangxi Institute of Biological Products?

Jiangxi Institute of Biological Products Inc. trades under the ticker 6915 on HKEX.

Where is Jiangxi Institute of Biological Products listed?

Jiangxi Institute of Biological Products Inc. is listed on HKEX.

Which country or territory is Jiangxi Institute of Biological Products listed under?

Our directory records Jiangxi Institute of Biological Products Inc. under China.

What does Jiangxi Institute of Biological Products do?

Our directory classifies Jiangxi Institute of Biological Products Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Jiangxi Institute of Biological Products?

The ISIN recorded for Jiangxi Institute of Biological Products Inc. is CNE100007Q61.

Does aibio.space cover Jiangxi Institute of Biological Products?

aibio.space lists Jiangxi Institute of Biological Products Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Jiangxi Institute of Biological Products?

Companies in our directory listed in the same country and business area as Jiangxi Institute of Biological Products: Viva Biotech Holdings, Qingdao Vland Biotech INC., AIM Vaccine Co., Ascletis Pharma, Zhengye Biotechnology Holding, Anhui Huaheng Biotechnology Co..

Investor discussion: Jiangxi Institute of Biological Products

Members talk about Jiangxi Institute of Biological Products (6915). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Jiangxi Institute of Biological Products, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: GLOBAL OFFERING. Source

Press releases

Headlines of Jiangxi Institute of Biological Products's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    New Arrangements of Electronic Dissemination of Corporate Communications

  2. HKEXnews

    New Arrangements on Dissemination of Corporate Communications

  3. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  4. HKEXnews

    VOLUNTARY ANNOUNCEMENT VETERINARY TETANUS ANTITOXIN PRODUCTION LINE OFFICIALLY COMMENCED PRODUCTION

  5. HKEXnews

    STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF OVER-ALLOTMENT OPTION

  6. HKEXnews

    VOLUNTARY ANNOUNCEMENT OBTAINING THE APPROVAL CERTIFICATE FOR VETERINARY TETANUS ANTITOXIN

  7. HKEXnews

    ANNOUNCEMENT OF ALLOTMENT RESULTS

  8. HKEXnews

    Terms of Reference of Sustainability Committee Under the Board of Directors

  9. HKEXnews

    Terms of Reference of Strategy and Investment Committee Under the Board of Directors

  10. HKEXnews

    Terms of Reference of Nomination Committee Under the Board of Directors

  11. HKEXnews

    Terms of Reference of Remuneration and Appraisal Committee Under the Board of Directors

  12. HKEXnews

    Terms of Reference of the Audit Committee under the Board of Directors

  13. HKEXnews

    Articles of Association

  14. HKEXnews

    Documents on Display

  15. HKEXnews

    GLOBAL OFFERING

  16. HKEXnews

    PHIP (1st submission)

  17. HKEXnews

    OC Announcement - Appointment

  18. HKEXnews

    Application Proof (1st submission)

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6915 on TradingView.

Listing details

Jiangxi Institute of Biological Products Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6915, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Jiangxi Institute of Biological Products Inc.
Ticker
6915
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
CNE100007Q61
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.